Laboratory Corp. of America Holdings (Public, NYSE:LH) https://www.labcorp.com/wps/portal/
IR: Laboratory Corporation of America - Investor Relations - Overview
GF: Laboratory Corp. of America Holdings: NYSE:LH quotes & news - Google Finance
YF: LH: Summary for Laboratory Corporation of Ameri- Yahoo! Finance
SA: Laboratory Corporation of America Holdings (LH) Stock - Seeking Alpha
SEC: EDGAR Search Results
LabCorp operates a nationwide network of 38 primary testing locations, more than 1,500 patient service centers, and routine testing is the cornerstone of the company's industry-leading national network. That delivery and service network makes it possible for LabCorp to easily offer an extensive esoteric testing portfolio and groundbreaking technologies to a broader audience, including medically important genomic tests. LabCorp's reputation and proven record in the area of advanced genomic testing continues to attract the leading minds and technological pioneers in the field. Its laboratories participated in the development of genomic applications using Polymerase Chain Reaction (PCR) technology and LabCorp was the first commercial laboratory to provide this innovative technology to health care providers. LabCorp laboratories have been at the forefront of new molecular tests to diagnose, treat and manage disease, particularly in the areas of infectious disease, oncology and genetics. LabCorp conducts clinical trials testing through its Esoterix clinical trials division.
IR: Laboratory Corporation of America - Investor Relations - Overview
GF: Laboratory Corp. of America Holdings: NYSE:LH quotes & news - Google Finance
YF: LH: Summary for Laboratory Corporation of Ameri- Yahoo! Finance
SA: Laboratory Corporation of America Holdings (LH) Stock - Seeking Alpha
SEC: EDGAR Search Results
LabCorp operates a nationwide network of 38 primary testing locations, more than 1,500 patient service centers, and routine testing is the cornerstone of the company's industry-leading national network. That delivery and service network makes it possible for LabCorp to easily offer an extensive esoteric testing portfolio and groundbreaking technologies to a broader audience, including medically important genomic tests. LabCorp's reputation and proven record in the area of advanced genomic testing continues to attract the leading minds and technological pioneers in the field. Its laboratories participated in the development of genomic applications using Polymerase Chain Reaction (PCR) technology and LabCorp was the first commercial laboratory to provide this innovative technology to health care providers. LabCorp laboratories have been at the forefront of new molecular tests to diagnose, treat and manage disease, particularly in the areas of infectious disease, oncology and genetics. LabCorp conducts clinical trials testing through its Esoterix clinical trials division.
